New national assignment for Xerum
The Umeå company Xerum has received a new national assignment to measure the presence of antibodies against SARS-CoV-2, the virus that causes covid-19 in Sweden. Xerum has performed and analyzed around 10 000 tests during the pandemic.
Mucocort signs new production deal for pain-relieving mouth ulcer treatment
Mucocort AB is a Swedish company that has developed a unique self-absorbing pain relief patch for people suffering from recurrent mouth ulcers - aphthous stomatitis. The company has now signed a production agreement with medical technology company Aurena Laboratories AB, which also becomes a stakeholder in Mucocort.
Omnio AB attracts EUR 1.5 million in capital investment and aims for first clinical trials in 2024
The Umeå-based biopharmaceutical company Omnio AB, focusing on wound healing, has received a capital injection of 1.5 million euros from its shareholders, which will be used for ongoing development work and to begin creating a blueprint for manufacturing.
New Head of PR and Communications at Umeå Biotech Incubator
Tomas Ruuth is the new Head of PR and Communications at Umeå Biotech Incubator.
Nordic Biomarker awarded as The Export Success of the Year in Sweden
The Umeå based company Nordic Biomarker has won the award The Export Success of the Year in Sweden.
Umeå company almost quadruples team as new antibody progresses to clinical trials
Umeå-based Lipum will reach an important milestone in its history this year as clinical trials begin on its antibody to treat inflammatory diseases. No less than 17 consultants are now involved in the drug’s development.
Swedish biotech company doubles workforce in two years, with continued hiring in focus to drive further growth
Swedish biotech company Agrisera has nearly doubled its workforce in the past two years, having recently moved to new and larger premises. “Demand for our products and services is increasing rapidly. We are in a growth phase and will seek additional talent in the future”, says Erika Gelfgren, CEO of Agrisera.
UBI organizes life science recruitment day
Umeå Biotech Incubator (UBI) is arranging a recruitment day with life science companies this May - and already 19 companies have signed up to take part. “We want students to get in touch with us. Recruitment opportunities are everything for life science companies”, says Jennie Ekbeck, CEO of Umeå Biotech Incubator.
Umeå Biotech Incubator gets EU grant extension
The life science industry in the Umeå region is on track to triple its turnover and double the number of people it employs by 2030. To help it reach this target, the Swedish Agency for Economic and Regional Growth has awarded Umeå Biotech Incubator (UBI) a grant of SEK 9.5 million.
QureTech Bio receives excellent support for development of new antibiotics
Umeå-based QureTech Bio AB receives support from the Swedish Research Council's major investment ENABLE-2, which in collaboration with Vinnova gives small and medium-sized companies access to the ENABLE-2 platform to continue development of new antibiotics.
Umeå Biotech companies raised SEK 301 Million in 2021
Companies and alumni from Umeå Biotech Incubator (UBI) raised SEK 301 million in capital investment and grants in 2021 - a huge increase of SEK 243 million compared to the previous year. “It’s an absolutely fantastic amount. We work hard to help companies attract investment, so it is clear that our incubator process is working. Of the companies that raised money, 50 percent have a female CEO, whi
New acne medicine takes one step closer to market launch
Umeå-based pharmaceutical company Vakona has signed an agreement with French company GTP Tech to initiate the first manufacturing steps of its acne medicine. “Production is at a level of quality that enables the medicine to be used in human clinical trials. If all goes well the medicine should be on the market within five to seven years”, says Mats Strömqvist, CEO and Chairman of the Board of Vak
Two more business coaches join Umeå Biotech Incubator
Umeå Biotech Incubator (UBI) has strengthened its team with the appointment of two new business coaches - Lisandro Bernardo and Tobias Tovedal. “There’s significant demand right now for business support, both in the early and late phases of development. We are extremely happy to welcome these two stars to our team”, says Jennie Ekbeck, CEO of Umeå Biotech Incubator.
UmanDiagnostics Appoints Business Development Manager
Ylva Elias has been appointed Business Development Manager at Swedish life science company UmanDiagnostics. She formerly took up her new position in January this year, and is responsible for selling and marketing UmanDiagnostics products throughout Europe.
Breakthrough for Inficure Bio about liver and kidney fibrosis
Inficure Bio a life science company focused on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions co-presented with CymaBay Therapeutics positive data at the American Association for the study of Liver Diseases (AASLD) using the company’s proprietary NIF mouse model.
Omnio AB raises 5.5 MSEK in fundraising round
Omnio AB is developing new drug products based on the pro-inflammatory and immune regulatory effects of the serum protein plasminogen. During fall the company successfully raised 5.5 MSEK in a new share issue and welcomed four new investors to the company. The added investments make it possible for the company to now initiate its planned activities to develop recombinant plasminogen for treatment
Umeå Biotech Incubator to open northern Sweden’s first life science networking pub
The northern Sweden’s first networking pub for people working in the life science industry will open its doors in Umeå on November 23rd. Behind the initiative is Umeå Biotech Incubator, which has previously been named Europe’s most innovative life science incubator. “In Umeå we think it is important to ‘pay it forward’. We want to help and support one another and create a strong sense of unity an
Multimillion SEK investment in Vakona signals start of production
Three investors are backing Umeå-based pharmaceutical company Vakona with funding worth millions of SEK. “We are absolutely delighted and proud to have attracted this investment. It’s a reward for many years of hard work and takes us one step closer to clinical human trials”, says Gabriella Persson, CEO of Vakona.
UmanDiagnostics launches new product that can revolutionize research in neurological diseases
Swedish-based UmanDiagnostics, a Quanterix company, has developed a new type of product that makes it easier to detect neurological diseases. Called NF-light ™ serum ELISA, it was officially launched on October 12th and will now be sold worldwide.
“Our product can be used for research inthe field of neurological diseases throughout the world. It feels very exciting, because our product is c
Umeå Biotech Incubator’s Jennie Ekbeck nominated for Sweden’s CEO of the Year
The CEO of Umeå Biotech Incubator (UBI), Jennie Ekbeck, has been named as one of five finalists in the small company category of Sweden’s CEO of the Year 2021.
“I was surprised and very happy to find out I had made it to the final. I feel really honoured”, says Jennie Ekbeck.
The award ceremony will be held at Fotografiska in Stockholm on 11th November.
A total of 20 nominees advanced to